JK06 Biparatopic 5T4-Targeted MMAE ADC: Overcoming the Challenges of a Difficult Target Through Rational Design

2:02 pm - Tuesday 9th March 2027

  • Review of the target and molecule design rationale
  • Overview of safety data and comparison with historical MMAE ADC safety data
  • Efficacy data in solid tumours, NSCLC and breast cancer

Speakers:

Chief Executive Officer
Salubris Biotherapeutics